Workflow
光正眼科: 新疆天阳律师事务所关于光正眼科医院集团股份有限公司2025年度第二次临时股东大会法律意见书

Core Viewpoint - The legal opinion issued by Xinjiang Tianyang Law Firm confirms that the procedures for the convening and holding of the 2025 Second Extraordinary General Meeting of Shareholders of Guangzheng Eye Hospital Group Co., Ltd. comply with relevant laws and regulations, ensuring the legality and validity of the meeting [1][5][6] Group 1: Meeting Procedures - The board of directors announced the notice for the 2025 Second Extraordinary General Meeting on July 17, 2025, and a supplementary notice on August 22, 2025, detailing the meeting's agenda, date, and voting procedures [3][4] - The meeting was convened by the sixth board of directors and conducted through a combination of on-site and online voting, held at the designated company meeting room [4][5] Group 2: Attendance Qualifications - A total of 232 shareholders and their proxies attended the meeting, representing 135,062,596 shares, which accounts for 26.0504% of the company's total share capital [5] - The controlling shareholder, Guangzheng Investment Co., Ltd., holds 24.9136% of the shares and proposed a temporary agenda item for the meeting [4][5] Group 3: Voting Procedures - The meeting voted on three agenda items using both on-site and online voting methods, with all items passing by a majority of over two-thirds of the valid votes cast [5][6] - The results of the voting were announced immediately following the completion of the voting process [5] Group 4: Conclusion - The legal opinion concludes that all aspects of the meeting, including the convening procedures, qualifications of attendees, voting methods, and results, are in compliance with the Company Law, Securities Law, and the company's articles of association, thus affirming the meeting's legality [5][6]